Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Trends and Collaborations in the IO Space

  • Broadcast in Science
  • 0 comments
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:10093801
archived

Dr Axel Hoos, GSK, leads a panel discussion on Trends and Collaborations in the Immuno-Oncology Space, featuring Dr Ramy Ibrahim, VP and Head of R&D, Parker Institute for Cancer Immunotherapy; Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs, Cancer Research Institute; Dr Daniel Chen, VP, Global Head of Cancer Immunotherapy Development, Genentech; and David Wholley, MPhil, Director, Research Partnerships Division, Foundation for the National Institutes of Health.

The 4th Annual IO360° conference will take place February 7-9, 2018 in New York City.

Comments

 comments